Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maryse Lowinski

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Biochemical Journal|August 25, 2004
UMP kinase from Streptococcus pneumoniae: evidence for co-operative ATP binding and allosteric regulationFlorence Fassy, Odile Krebs, Maryse Lowinski, et al.
Journal of Chemical Information and Modeling|November 8, 2019
Estimation of Protein-Ligand Unbinding Kinetics Using Non-Equilibrium Targeted Molecular Dynamics SimulationsSteffen Wolf, Marta Amaral, Maryse Lowinski, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2013
The use of virtual screening and differential scanning fluorimetry for the rapid identification of fragments active against MEK1Kwame Amaning, Maryse Lowinski, Francois Vallee, et al.
Journal of Chemical Theory and Computation|May 18, 2018
Estimation of Drug-Target Residence Times by τ-Random Acceleration Molecular Dynamics SimulationsDaria B Kokh, Marta Amaral, Joerg Bomke, et al.
Small Gtpases|September 24, 2021
KRAS G12C fragment screening renders new binding pocketsMagali Mathieu, Valérie Steier, Florence Fassy, et al.
Journal of Medicinal Chemistry|June 30, 2016
Discovery and Pharmacokinetic and Pharmacological Properties of the Potent and Selective MET Kinase Inhibitor 1-{6-[6-(4-Fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea (SAR125844)Antonio Ugolini, Mireille Kenigsberg, Alexey Rak, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Biochemical Journal|August 25, 2004
UMP kinase from Streptococcus pneumoniae: evidence for co-operative ATP binding and allosteric regulationFlorence Fassy, Odile Krebs, Maryse Lowinski, et al.
Journal of Chemical Information and Modeling|November 8, 2019
Estimation of Protein-Ligand Unbinding Kinetics Using Non-Equilibrium Targeted Molecular Dynamics SimulationsSteffen Wolf, Marta Amaral, Maryse Lowinski, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2013
The use of virtual screening and differential scanning fluorimetry for the rapid identification of fragments active against MEK1Kwame Amaning, Maryse Lowinski, Francois Vallee, et al.
Journal of Chemical Theory and Computation|May 18, 2018
Estimation of Drug-Target Residence Times by τ-Random Acceleration Molecular Dynamics SimulationsDaria B Kokh, Marta Amaral, Joerg Bomke, et al.
Small Gtpases|September 24, 2021
KRAS G12C fragment screening renders new binding pocketsMagali Mathieu, Valérie Steier, Florence Fassy, et al.
Journal of Medicinal Chemistry|June 30, 2016
Discovery and Pharmacokinetic and Pharmacological Properties of the Potent and Selective MET Kinase Inhibitor 1-{6-[6-(4-Fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea (SAR125844)Antonio Ugolini, Mireille Kenigsberg, Alexey Rak, et al.
Pageof 1